| Financier | Commitments |
|---|---|
| IDA Credit | 10.00 |
| Borrower/Recipient | 377.18 |
| Program-for-Results Support MDTF | 14.75 |
| IDA Grant | 10.00 |
Primary Health Care Quality Improvement Program
Abstract*
The original Program for Results (PforR) focuses on three results areas: (a) Result area 1: Integrating sustainable quality improvement mechanisms into service delivery; (b) Result area 2: Strengthening strategic purchasing for the quality of care; and (c) Result area 3: Strengthening health sector stewardship and governance for quality improvement. The proposed additional financing (AF) will be processed as a new IPF component to the PforR and is... Show More
Development Objective
The Program Development Objective is to contribute to improving the quality of primary health care services in the Kyrgyz Republic.
Key Details
Project Details
P167598
Active
Mohini Kak , Sven Neelsen
Kyrgyz Republic
September 6, 2018
(as of board presentation)
June 7, 2019
June 7, 2020
US$ 414.18 million
Ministry of Health,Mandatory Health Insurance Fund
2019
US$ 34.75 million
N/A
June 27, 2024
June 30, 2026
No
BANK APPROVED
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | 20.00 |
| IBRD + IDA Commitment | 20.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | 14.75 |
| Total Project Cost** | 414.18 |
Summary Status of World Bank Financing (US$ Millions) as of February 28, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Oct 15, 2021 | IDA-64140 | Int Charges | 9,234.82 |
| Oct 15, 2021 | IDA-64140 | Int Charges | 9,234.82 |
| Oct 15, 2021 | IDA-64140 | Int Charges | 93.66 |
| Oct 15, 2021 | IDA-64140 | Int Charges | 93.66 |
| Apr 15, 2021 | IDA-64140 | Int Charges | 1,573.16 |
| Apr 15, 2021 | IDA-64140 | Int Charges | 1,573.16 |
| Jun 9, 2023 | IDA-64140 | Loan Disb | 191,822.40 |
| Apr 15, 2023 | IDA-64140 | Int Charges | 289.98 |
| Apr 15, 2023 | IDA-64140 | Int Charges | 289.98 |
| Jun 7, 2019 | IDA-64140 | Loan Commitment | 10,000,000.00 |
| Jun 7, 2019 | IDA-D4680 | Loan Commitment | 10,000,000.00 |
| Jul 18, 2024 | IDA-64140 | Loan Disb | 765,544.30 |
| Apr 15, 2023 | IDA-64140 | Int Charges | 8,546.27 |
| Apr 15, 2023 | IDA-64140 | Int Charges | 8,546.27 |
| Oct 15, 2022 | IDA-64140 | Int Charges | 227.55 |
| Oct 15, 2022 | IDA-64140 | Int Charges | 227.55 |
| Oct 15, 2022 | IDA-64140 | Int Charges | 8,206.47 |
| Oct 15, 2022 | IDA-64140 | Int Charges | 8,206.47 |
| Apr 15, 2024 | IDA-64140 | Int Charges | 158.56 |
| Apr 15, 2024 | IDA-64140 | Int Charges | 158.56 |
| Apr 15, 2024 | IDA-64140 | Int Charges | 9,249.72 |
| Apr 15, 2024 | IDA-64140 | Int Charges | 9,249.72 |
| Oct 15, 2023 | IDA-64140 | Int Charges | 109.97 |
| Oct 15, 2023 | IDA-64140 | Int Charges | 109.97 |
| Oct 15, 2023 | IDA-64140 | Int Charges | 9,149.97 |
| Oct 15, 2023 | IDA-64140 | Int Charges | 9,149.97 |
| Sep 15, 2020 | IDA-D4680 | Loan Disb | 2,495,978.00 |
| Apr 15, 2021 | IDA-64140 | Int Charges | 9,438.96 |
| Apr 15, 2021 | IDA-64140 | Int Charges | 9,438.96 |
| Sep 15, 2020 | IDA-64140 | Loan Disb | 2,495,978.00 |
| Jul 18, 2024 | IDA-D4680 | Loan Disb | 1,339,702.50 |
| Jun 6, 2023 | IDA-D4680 | Loan Disb | 1,568,326.20 |
| Jun 27, 2023 | IDA-D4680 | Loan Disb | 481,064.40 |
| Apr 15, 2022 | IDA-64140 | Int Charges | 8,972.03 |
| Apr 15, 2022 | IDA-64140 | Int Charges | 8,972.03 |
| Apr 15, 2022 | IDA-64140 | Int Charges | 55.97 |
| Apr 15, 2022 | IDA-64140 | Int Charges | 55.97 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Progress towards achievement of PDO | Moderately Satisfactory | 2024-12-05 |
| Monitoring and Evaluation | Moderately Satisfactory | 2024-12-05 |
| Overall Implementation Progress (IP) | Moderately Satisfactory | 2024-12-05 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
PDO 1: Number of pregnant women who received hemoglobin test and urine analysis for bacteriuria during the first trimester in a public PHC, GPC, or SSES laboratory. Value 24000.00 48562.00 48000.00 Date December 31, 2018 December 31, 2023 December 31, 2025 Comment PDO 2: Number of patients with diabetes or suspected diabetes who receive an HbA1c test during the calendar year in a public PHC facility or the Republican Endocrinology Center Value 0.00 22302.00 20000.00 Date December 31, 2018 December 31, 2023 December 31, 2025 Comment PDO 3: Increase in drug coverage for priority conditions under the ADP, as measured by number of prescriptions reimbursed for (i) Test strips, (ii) Iron supplements, and (iii) Hypertension drugs Value (i) 3,149 (ii) 169,480 (iii) 333,545 (i) 129,968; (ii) 1,134,046; (iii) 1,914,867 (i) 22,200 (ii) 1,224,000 (iii) 2,429,000 Date December 31, 2017 December 31, 2023 December 31, 2025 Comment PDO 4: A unit fully designated to quality improvement is established within the MoH and functioning Value No Yes Yes Date December 31, 2018 December 31, 2023 December 31, 2025 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
IRI 6 - The SGBP is revised to improve coverage for selected priority conditions at PHC. Value No revision. Partial revision as per indicator framework was co The PHC services and out-patient drug packages are Date December 31, 2018 March 31, 2024 December 31, 2025 Comment IRI 1- Number of online learning curricula on priority conditions and topics developed, approved, and available in the online CPD platform Value 0.00 16.00 20.00 Date December 31, 2018 December 31, 2023 December 31, 2025 Comment IRI 9 - Number of meetings by the Coordination Committee of the QI unit to discuss quality issues and actions Value 0.00 0.00 10.00 Date December 31, 2018 December 31, 2022 December 31, 2025 Comment IRI 7 - The PHC payment mechanism is revised. Value Capitation payment system does not incorporate adj Procedure classification for PHC is developed and At least one pay-for-quality mechanism complements Date December 31, 2018 March 31, 2024 December 31, 2025 Comment IRI 2 - Number of PHC physicians who complete at least one approved online PHC course with credit hours Value 0.00 251.00 900.00 Date December 31, 2018 December 31, 2023 December 31, 2025 Comment IRI 10 - Number of clinical guidelines revised or developed Value 0.00 42.00 30.00 Date December 31, 2018 December 31, 2023 December 31, 2025 Comment IRI 8 - The drugs list under the ADP program is revised to prioritize spending on evidence-based generic medications. Value No No Yes Date December 31, 2018 March 31, 2024 December 31, 2025 Comment IRI 11 - Number of PHC organizations receiving reports from the QI Unit on their own performance with benchmarking (at least twice in the calendar year) Value 0.00 0.00 79.00 Date December 31, 2018 December 31, 2023 December 31, 2025 Comment IRI 4 - Number of suspected or confirmed diabetic patients (type I or II) who received an HbA1C test in a public PHC facility or atthe Republican Endocrinology Center Value 0.00 22302.00 20000.00 Date December 31, 2018 December 31, 2023 December 31, 2025 Comment IRI 12 - Number of PHC organizations whose Quality Committee receives training on quality improvement (at least once a year) Value 0.00 15.00 79.00 Date December 31, 2018 June 15, 2024 December 31, 2025 Comment IRI 13 - Number of PHC organizations that pilot a new mechanism to collect and process patient feedback and complaints. Value 0.00 0.00 15.00 Date December 31, 2018 March 31, 2024 December 31, 2025 Comment IRI 4.1 - Number of men Value 0.00 5652.00 7000.00 Date December 31, 2018 December 31, 2022 December 31, 2025 Comment IRI 4.2 - Number of women Value 0.00 8712.00 13000.00 Date December 31, 2018 December 31, 2022 December 31, 2025 Comment People who have received essential health, nutrition, and population (HNP) services Value 0.00 1099729.00 1350000.00 Date December 31, 2018 December 31, 2023 December 31, 2024 Comment Number of children immunized Value 0.00 1099729.00 1350000.00 Date December 31, 2018 December 31, 2023 December 31, 2024 Comment